Clinical Trial

A Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have Narcolepsy

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the trial is to determine if Lu AH69593 is safe and well tolerated. The trial will also look at how the body processes Lu AH69593 with and without food.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-12-01 -> 2027-02-09 2026-08-13
minor Completion pushed: 2026-12-18 -> 2027-02-16 2026-08-13
Trial Details
NCT Number NCT07613710
Lead Sponsor H. Lundbeck A/S
Conditions Narcolepsy
Enrollment 104 participants
Start Date 2025-06-13
Primary Completion 2027-02-09 (estimated)
Study Completion 2027-02-16 (estimated)
Updated on ClinicalTrials.gov 2026-08-12